UBP
INMB icon

Union Bancaire Privee’s INmune Bio INMB Stock Holding History

Union Bancaire Privee’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$1.36K – 517
2025
Q4 		$1.36K Hold
1,000
– – ﹤0.01% 477
2025
Q3 		$1.71K Hold
1,000
– – ﹤0.01% 471
2025
Q2 		$4.55K Buy
+1,000
New +$7.34K ﹤0.01% 476

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Union Bancaire Privee's INMB Position: Q1 2026 in Review

Union Bancaire Privee sold out of INmune Bio (INMB) in Q1 2026, closing a stake of 1,000 shares — an estimated $1.36K sold.

Union Bancaire Privee first reported a position in INMB in Q2 2025 and held it in 3 quarters. The position peaked at $4.55K in Q2 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Union Bancaire Privee reported no remaining INmune Bio position as of Q1 2026 after selling out during the quarter.
  • Union Bancaire Privee sold 1,000 INmune Bio shares in Q1 2026, an estimated $1.36K.
  • Union Bancaire Privee first reported a position in INmune Bio in Q2 2025 and held it in 3 quarters.
  • Union Bancaire Privee's INmune Bio position peaked at $4.55K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Union Bancaire Privee's 13F filing for Q1 2026, filed 22 Apr 2026.